Form 4: ResMed Director Richard Sulpizio Acquires 1,083 Shares Through Restricted Stock Units
SEC Form 4 Filing
ResMed director Richard Sulpizio acquired 1,083 shares of common stock through the vesting of restricted stock units.
Summary
- Richard Sulpizio, a director at ResMed Inc., acquired 1,083 shares of ResMed common stock on November 20, 2024.
- The acquisition was through the vesting of restricted stock units (RSUs).
- These RSUs will vest on the earlier of November 11, 2025, or the annual shareholder's meeting in the year following the grant date.
- Following this transaction, Mr. Sulpizio now beneficially owns 17,796 shares of ResMed common stock.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction related to executive compensation, which is generally viewed neutrally to positively. The acquisition of shares by a director can be seen as a positive sign of confidence in the company.
Positives
- The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future.
Industry Context
This is a routine filing related to executive compensation and is common for publicly traded companies. It reflects the standard practice of using stock-based compensation to align the interests of management with those of shareholders.
Comparison to Industry Standards
- Stock-based compensation, such as restricted stock units, is a common practice among publicly traded companies, particularly in the technology and healthcare sectors, to incentivize and retain key personnel.
- The vesting schedule of the RSUs, with a cliff vest date, is also a standard practice to ensure long-term commitment from the recipient.
- Companies like Philips and Medtronic, which are competitors of ResMed, also use similar stock-based compensation plans for their executives.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it aligns the director's interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 11/20/2024 | Date of the transaction where Richard Sulpizio acquired shares. |
| 11/11/2025 | Earliest possible vesting date for the restricted stock units. |
Keywords
ResMed, Director, Richard Sulpizio, Stock Acquisition, Restricted Stock Units, RSU, Share Ownership, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.